{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:49:42Z","timestamp":1777621782720,"version":"3.51.4"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.actatropica.2019.04.020","type":"journal-article","created":{"date-parts":[[2019,4,27]],"date-time":"2019-04-27T10:42:24Z","timestamp":1556361744000},"page":"103-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Nano-facilitated drug delivery strategies in the treatment of plasmodium infection"],"prefix":"10.1016","volume":"195","author":[{"given":"Nethravathi","family":"Puttappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raman Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gowthamarajan","family":"Kuppusamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arun","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.actatropica.2019.04.020_bib0005","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/qua.25189","article-title":"Electronic structure and conformational analysis of P218: an antimalarial drug candidate","volume":"116","author":"Abbat","year":"2016","journal-title":"Int. J. Quantum. Chem."},{"issue":"22","key":"10.1016\/j.actatropica.2019.04.020_bib0010","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1016\/j.biomaterials.2007.04.004","article-title":"Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate","volume":"28","author":"Agrawal","year":"2007","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12951-016-0179-8","article-title":"Short peptide-based nanotubes capable of effective curcumin delivery for treating drug resistant malaria","volume":"14","author":"Alam","year":"2016","journal-title":"J. NanoBiotechnol."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3109\/21691401.2014.968821","article-title":"Development and characterization of arteether-loaded nanostructured lipid carriers for the treatment of malaria","volume":"44","author":"Ali","year":"2016","journal-title":"Artificial. Cells. Nanomed. Biotechnol."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0025","first-page":"339","article-title":"Liposomes as vehicles for vaccines","volume":"47","author":"Alving","year":"1980","journal-title":"Progress. Clinical. Bio. Res."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0030","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1038\/s41598-018-21351-8","article-title":"Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance","volume":"8","author":"Amolegbe","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0035","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nnm.15.181","article-title":"Antiparasitic and immunomodulatory potential of oral nanocapsules encapsulated lactoferrin protein against Plasmodium berghei","volume":"11","author":"Anand","year":"2016","journal-title":"Nanomed."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41467-017-02603-z","article-title":"Long-acting injectable atovaquone nanomedicines for malaria prophylaxis","volume":"9","author":"Bakshi","year":"2018","journal-title":"Nat. Commu."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12936-017-1787-y","article-title":"World malaria report: time to acknowledge plasmodium knowlesi malaria","volume":"16","author":"Barber","year":"2017","journal-title":"Malaria J."},{"issue":"7","key":"10.1016\/j.actatropica.2019.04.020_bib0050","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/1061186X.2017.1390671","article-title":"Optimisation of chloroquine phosphate loaded nanostructured lipid carriers using Box\u2013Behnken design and its antimalarial efficacy","volume":"26","author":"Baruah","year":"2018","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.actatropica.2019.04.020_bib0055","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.3390\/molecules14083037","article-title":"Plant-derived antimalarial agents: new leads and efficient phytomedicines. Part II. Non-alkaloidal natural products","volume":"14","author":"Batista","year":"2009","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.actatropica.2019.04.020_bib0060","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1128\/AAC.00243-15","article-title":"Efficacy of a novel sublingual spray formulation of artemether in African children with Plasmodium falciparum malaria","volume":"59","author":"Bendel","year":"2015","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"1-2","key":"10.1016\/j.actatropica.2019.04.020_bib0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ijpharm.2005.01.026","article-title":"Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting","volume":"295","author":"Bhadra","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0070","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11095-005-9396-9","article-title":"PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate","volume":"23","author":"Bhadra","year":"2006","journal-title":"Pharm. Res."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11095-005-9396-9","article-title":"PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate","volume":"23","author":"Bhadra","year":"2006","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.actatropica.2019.04.020_bib0080","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1016\/j.bmcl.2013.03.067","article-title":"Recent advances in malaria drug discovery","volume":"23","author":"Biamonte","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1-2","key":"10.1016\/j.actatropica.2019.04.020_bib0085","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijpharm.2011.12.040","article-title":"Clotrimazole nanoemulsion for malaria Chemothertherapy. Part I: Preformulation studies, formulation design and physicochemical evaluation","volume":"431","author":"Borhade","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2019.04.020_bib0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ijpharm.2011.12.031","article-title":"Clotrimazole nanoemulsion for malaria Chemothertherapy. Part II: Stability assessment., in vivo pharmacodynamic evaluations and toxicological studies","volume":"431","author":"Borhade","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijpharm.2011.01.048","article-title":"Cationic nanoemulsion as a delivery system for oligonucleotides targeting malarial topoisomerase II","volume":"416","author":"Bruxel","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.actatropica.2019.04.020_bib0100","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3109\/03639045.2012.658812","article-title":"Artesunate-loaded chitosan\/lecithin nanoparticles: preparation, characterization, and in vivo studies","volume":"38","author":"Chadha","year":"2012","journal-title":"Drug. Dev. Ind. Pharm."},{"issue":"11","key":"10.1016\/j.actatropica.2019.04.020_bib0105","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1073\/pnas.1015762108","article-title":"Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria","volume":"108","author":"Charman","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0731-7085(01)00611-2","article-title":"Preparation of \u03b2-artemether liposomes, their HPLC\u2013UV evaluation and relevance for clearing recrudescent parasitaemia in Plasmodium chabaudi malaria-infected mice","volume":"28","author":"Chimanuka","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0115","series-title":"First-in-Human Trial of Single Ascending Dose, Multiple Ascending Dose and Malaria Challenge Model in Healthy Subjects NCT03261401","author":"ClinicalTrials.gov","year":"2017"},{"issue":"6","key":"10.1016\/j.actatropica.2019.04.020_bib0120","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1083\/jcb.201206112","article-title":"The cellular and molecular basis for malaria parasite invasion of the human red blood cell","volume":"198","author":"Cowman","year":"2012","journal-title":"J. Cell. Biol."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1756-3305-3-5","article-title":"History of the discovery of the malaria parasites and their vectors","volume":"3","author":"Cox","year":"2010","journal-title":"Parasites Vectors"},{"issue":"12","key":"10.1016\/j.actatropica.2019.04.020_bib0130","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1002\/jps.22191","article-title":"Curcumin-loaded hydrogel nanoparticles: application in anti-malarial therapy and toxicological evaluation","volume":"99","author":"Dandekar","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0135","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejps.2017.09.051","article-title":"Atovaquone oral bioavailability enhancement using electrospraying technology","volume":"111","author":"Darade","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.actatropica.2019.04.020_bib0140","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1080\/21691401.2016.1198365","article-title":"Structural characterization and evaluation of mosquito-larvicidal property of silver nanoparticles synthesized from the seaweed, Turbinaria ornata (Turner) J Agardh 1848","volume":"45","author":"Deepak","year":"2017","journal-title":"Art. Cells Nanomed. Biotechnol."},{"issue":"1-2","key":"10.1016\/j.actatropica.2019.04.020_bib0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2005.07.015","article-title":"Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy","volume":"303","author":"Dierling","year":"2005","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0150","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/nrmicro2331","article-title":"Artemisinin resistance: current status and scenarios for containment","volume":"8","author":"Dondorp","year":"2010","journal-title":"Nat. Rev. Microbiol."},{"issue":"110","key":"10.1016\/j.actatropica.2019.04.020_bib0155","doi-asserted-by":"crossref","first-page":"64905","DOI":"10.1039\/C4RA09267H","article-title":"Self-nanoemulsifying drug delivery systems (SNEDDS) for oral delivery of arteether: pharmacokinetics, toxicity and antimalarial activity in mice","volume":"4","author":"Dwivedi","year":"2014","journal-title":"RSC Adv."},{"issue":"1-2","key":"10.1016\/j.actatropica.2019.04.020_bib0160","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2014.03.036","article-title":"Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats","volume":"466","author":"Dwivedi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtm.2017.08.004","article-title":"DNA-loaded cationic liposomes efficiently function as a vaccine against malarial proteins","volume":"7","author":"Fotoran","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0170","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0731-7085(02)00678-7","article-title":"Physical and chemical evaluation of liposomes, containing artesunate","volume":"31","author":"Gabriels","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"10","key":"10.1016\/j.actatropica.2019.04.020_bib0175","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.3390\/molecules22101581","article-title":"Function oriented molecular design: dendrimers as novel Antimicrobbials","volume":"22","author":"Garc\u00eda-Gallego","year":"2017","journal-title":"Molecules"},{"issue":"31","key":"10.1016\/j.actatropica.2019.04.020_bib0180","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2017.05.070","article-title":"Liposomes containing monophosphoryl lipid a and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013","volume":"35","author":"Genito","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0185","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.2147\/IJN.S62756","article-title":"Formulation of nanotized curcumin and demonstration of its antimalarial efficacy","volume":"9","author":"Ghosh","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0190","series-title":"Vaccine Adjuvants","first-page":"137","article-title":"Liposomes as immunological adjuvants and vaccine carriers","author":"Gregoriadis","year":"2000"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0195","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1051\/parasite\/2008153219","article-title":"Discovery of new targets for antimalarial chemothertherapy","volume":"15","author":"Grellier","year":"2009","journal-title":"Parasite"},{"issue":"7","key":"10.1016\/j.actatropica.2019.04.020_bib0200","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1211\/jpp.59.7.0004","article-title":"Transferrin\u2010conjugated solid lipid nanoparticles for enhanced delivery of quinine dihydrochloride to the brain","volume":"59","author":"Gupta","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0205","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ijantimicag.2009.02.024","article-title":"Nanoencapsulation increases quinine antimalarial efficacy against Plasmodium berghei in vivo","volume":"34","author":"Haas","year":"2009","journal-title":"Int. J. Antimic Agents"},{"issue":"11","key":"10.1016\/j.actatropica.2019.04.020_bib0210","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1517\/17460441.2013.843522","article-title":"Novel approaches in antimalarial drug discovery","volume":"8","author":"Held","year":"2013","journal-title":"Experts Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0215","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01940-16","article-title":"Estimation of the in vivo MIC of cipargamin in uncomplicated Plasmodium falciparum malaria","volume":"61","author":"Hien","year":"2017","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"1-2","key":"10.1016\/j.actatropica.2019.04.020_bib0220","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijpharm.2014.01.001","article-title":"Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy","volume":"464","author":"Ibrahim","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0225","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijpharm.2015.09.020","article-title":"Artemisinin nanoformulation suitable for intravenous injection: preparation, characterization and antimalarial activities","volume":"495","author":"Ibrahim","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.actatropica.2019.04.020_bib0230","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1248\/bpb.b16-00914","article-title":"Effective-loading of platinum\u2013chloroquine into PEGylated neutral and cationic liposomes as a drug delivery system for resistant malaria parasites","volume":"40","author":"Ibrahim","year":"2017","journal-title":"Bio. Pharm. Bull."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0235","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: enhanced antimalarial efficacy against Plasmodium berghei-infected mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur. Pharm. BioPharm."},{"issue":"7","key":"10.1016\/j.actatropica.2019.04.020_bib0240","doi-asserted-by":"crossref","first-page":"940","DOI":"10.3109\/10717544.2014.885999","article-title":"Optimization of artemether-loaded NLC for intranasal delivery using central composite design","volume":"22","author":"Jain","year":"2015","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0245","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1177\/1091581816652605","article-title":"Teratogenicity of artemether\u2013clindamycin nanostructured lipid carriers in rats","volume":"35","author":"Jain","year":"2016","journal-title":"Int. J. Toxicol."},{"issue":"50","key":"10.1016\/j.actatropica.2019.04.020_bib0250","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1073\/pnas.1414221111","article-title":"(+)-SJ733, A clinical candidate for malaria that acts through ATP4 to induce rapid host-mediated clearance of Plasmodium","volume":"111","author":"Jimenez-Diaz","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0255","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2008.07.032","article-title":"Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: nanoject","volume":"364","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1-2","key":"10.1016\/j.actatropica.2019.04.020_bib0260","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ijpharm.2008.06.012","article-title":"Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria","volume":"362","author":"Joshi","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.actatropica.2019.04.020_bib0265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0164895","article-title":"Inhibition of an erythrocyte tyrosine kinase with imatinib prevents Plasmodium falciparum egress and terminates parasitemia","volume":"11","author":"Kesely","year":"2016","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.actatropica.2019.04.020_bib0270","doi-asserted-by":"crossref","first-page":"5060","DOI":"10.1128\/AAC.02727-13","article-title":"KAF156 is an antimalarial clinical candidate with potential for use in prophylaxis. treatment, and prevention of disease transmission","volume":"58","author":"Kuhen","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"39","key":"10.1016\/j.actatropica.2019.04.020_bib0275","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.vaccine.2015.08.025","article-title":"Nanovaccines for malaria using Plasmodium falciparum antigen Pfs25 attached gold nanoparticles","volume":"33","author":"Kumar","year":"2015","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.actatropica.2019.04.020_bib0280","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1128\/AAC.03478-14","article-title":"A first-in-human randomized., double-blind, placebo-controlled, single-and multiple-ascending oral dose study of novel Imidazolopiperazine KAF156 to assess its safety, tolerability, and pharmacokinetics in healthy adult volunteers","volume":"58","author":"Leong","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0285","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1098\/rsfs.2012.0009","article-title":"Peptide-and saccharide-conjugated dendrimers for targeted drug delivery: a concise review","volume":"2","author":"Liu","year":"2012","journal-title":"Interface Focus"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0290","first-page":"33","article-title":"Novel nanostructured lipid carrier for oral delivery of a poorly soluble antimalarial agent lumefantrine: characterization and pharmacokinetics evaluation","volume":"5","author":"Liu","year":"2018","journal-title":"MOJ. Bioequiv. Availab."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0295","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s11095-006-9609-x","article-title":"Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence","volume":"23","author":"Longmuir","year":"2006","journal-title":"Pharm. Res."},{"issue":"1-2","key":"10.1016\/j.actatropica.2019.04.020_bib0300","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2009.07.030","article-title":"Liposomal delivery of doxorubicin to hepatocytes in vivo by targeting heparan sulfate","volume":"382","author":"Longmuir","year":"2009","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.actatropica.2019.04.020_bib0305","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1021\/acsinfecdis.7b00278","article-title":"Encapsulation of OZ439 into nanoparticles for supersaturated drug release in oral malaria therapy","volume":"4","author":"Lu","year":"2018","journal-title":"ACS. Inf. Dis."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0310","first-page":"272","article-title":"Design and in vitro evaluation of nanoemulsion for nasal delivery of artemether","volume":"3","author":"Mahajan","year":"2011","journal-title":"IJNDD"},{"issue":"9","key":"10.1016\/j.actatropica.2019.04.020_bib0315","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1128\/AAC.01375-10","article-title":"Ex vivo drug susceptibility of ferroquine against chloroquine-resistant isolates of Plasmodium falciparum and P. vivax","volume":"55","author":"Marfurt","year":"2011","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"8","key":"10.1016\/j.actatropica.2019.04.020_bib0320","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.nano.2014.06.002","article-title":"Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells","volume":"10","author":"Marques","year":"2014","journal-title":"Nanomed. Nanotechnol. Bio. Med."},{"issue":"7","key":"10.1016\/j.actatropica.2019.04.020_bib0325","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1039\/c1md00102g","article-title":"Second generation analogues of RKA182, synthetic tetraoxanes with outstanding in vitro and in vivo antimalarial activities","volume":"2","author":"Marti","year":"2011","journal-title":"Med. Chem. Comm."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0330","first-page":"225","article-title":"Polyamidoamine nanoparticles for the oral administration of antimalarial drugs","volume":"10","author":"Mart\u00edComa-Cros","year":"2018","journal-title":"Pharmaceutical"},{"issue":"9","key":"10.1016\/j.actatropica.2019.04.020_bib0335","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1093\/jac\/dkw174","article-title":"Efficacy of OZ439 (artefenomel) against early Plasmodium falciparum blood-stage malaria infection in healthy volunteers","volume":"71","author":"McCarthy","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0340","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejpb.2012.05.004","article-title":"Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of \u03b2-arteether","volume":"82","author":"Memvanga","year":"2012","journal-title":"Eur. J. Pharm. BioPharm."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0345","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jconrel.2013.09.001","article-title":"An oral malaria therapy: curcumin-loaded lipid-based drug delivery systems combined with \u03b2-arteether","volume":"172","author":"Memvanga","year":"2013","journal-title":"J. Control. Release"},{"issue":"10","key":"10.1016\/j.actatropica.2019.04.020_bib0350","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1007\/s11095-013-1094-4","article-title":"In vitro lipolysis and intestinal transport of \u03b2-arteether-loaded lipid-based drug delivery systems","volume":"30","author":"Memvanga","year":"2013","journal-title":"Pharm. Res."},{"issue":"6872","key":"10.1016\/j.actatropica.2019.04.020_bib0355","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/415673a","article-title":"The pathogenic basis of malaria","volume":"415","author":"Miller","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0360","first-page":"1","article-title":"Cu-Zn and Ag-Cu bimetallic nanoparticles as larvicide to control malaria parasite vector: a comparative analysis","author":"Minal","year":"2016","journal-title":"2016 IEEE Region 10 Humanitarian Technology Conference (R10-HTC)"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0365","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2015.05.284","article-title":"Immunoliposome-mediated drug delivery to Plasmodium-infected and non-infected red blood cells as a dual therapeutic\/prophylactic antimalarial strategy","volume":"210","author":"Moles","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0370","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jconrel.2016.09.006","article-title":"Development of drug-loaded immunoliposomes for the selective targeting and elimination of rosetting Plasmodium falciparum-infected red blood cells","volume":"241","author":"Moles","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0375","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biomaterials.2017.08.020","article-title":"ImmunoPEG liposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model","volume":"145","author":"Moles","year":"2017","journal-title":"Biomaterials."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0380","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1475-2875-10-53","article-title":"Phase I randomized dose-ascending placebo-controlled trials of ferroquine-a candidate anti-malarial drug-in adults with asymptomatic Plasmodium falciparum infection","volume":"10","author":"Mombo-Ngoma","year":"2011","journal-title":"Malaria J."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0385","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1128\/AAC.48.4.1222-1228.2004","article-title":"Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice","volume":"48","author":"Mosqueira","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"issue":"27","key":"10.1016\/j.actatropica.2019.04.020_bib0390","doi-asserted-by":"crossref","first-page":"7940","DOI":"10.1016\/j.biomaterials.2014.05.061","article-title":"Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs","volume":"35","author":"Movellan","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0395","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12936-018-2302-9","article-title":"In vitro evaluation of chloroquine-loaded and heparin surface-functionalized solid lipid nanoparticles","volume":"17","author":"Muga","year":"2018","journal-title":"Malaria J."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0400","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.colsurfb.2010.07.020","article-title":"Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment","volume":"81","author":"Nayak","year":"2010","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0405","doi-asserted-by":"crossref","DOI":"10.14233\/ajchem.2015.19087","article-title":"Synthesis of naphthoquinone dendrimer based materials as potential antimalarial drugs","volume":"27","author":"Ndior","year":"2015","journal-title":"Asian J. Chem."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2019.04.020_bib0410","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2014.10.004","article-title":"Development of artemether-loaded nanostructured lipid carrier (NLC) formulation for topical application","volume":"477","author":"Nnamani","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0415","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0163-7258(98)00036-9","article-title":"An overview of chemothertherapeutic targets for antimalarial drug discovery","volume":"81","author":"Olliaro","year":"1999","journal-title":"Pharmacol. Therapeu."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0420","first-page":"3865","article-title":"Preparation, characterization, and optimization of primaquine-loaded solid lipid nanoparticles","volume":"9","author":"Omwoyo","year":"2014","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0425","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.nano.2015.11.017","article-title":"Development, characterization and antimalarial efficacy of dihydroartemisinin loaded solid lipid nanoparticles","volume":"12","author":"Omwoyo","year":"2016","journal-title":"Nanomed. Nanotech. Bio. Med."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0430","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3389\/fphar.2018.00562","article-title":"Curcumin-artesunate based polymeric nanoparticle. Antiplasmodial and toxicological evaluation in murine model","volume":"9","author":"Oyeyemi","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.actatropica.2019.04.020_bib0435","first-page":"208","article-title":"Potential anti-plasmodial activity of synthesized silver nanoparticle using Andrographis paniculata Nees (Acanthaceae)","volume":"3","author":"Panneerselvam","year":"2011","journal-title":"Arch. Appl. Sci. Res."},{"issue":"387","key":"10.1016\/j.actatropica.2019.04.020_bib0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aad9735","article-title":"Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase","volume":"9","author":"Paquet","year":"2017","journal-title":"Sci. Trans. Med."},{"issue":"296","key":"10.1016\/j.actatropica.2019.04.020_bib0445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.aaa6645","article-title":"A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria","volume":"7","author":"Phillips","year":"2015","journal-title":"Sci. Trans. Med."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0450","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1473-3099(15)00320-5","article-title":"Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial","volume":"16","author":"Phyo","year":"2016","journal-title":"Lancet Inf. Dis."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0455","series-title":"An Illustrated History of Malaria","author":"Poser","year":"1999"},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0460","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ijpharm.2016.07.021","article-title":"Artemether lumefantrine nanostructured lipid carriers for oral malaria therapy: enhanced efficacy at reduced dose and dosing frequency","volume":"511","author":"Prabhu","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2019.04.020_bib0465","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ijpharm.2016.09.008","article-title":"Nanostructured lipid carriers of artemether\u2013lumefantrine combination for intravenous therapy of cerebral malaria","volume":"513","author":"Prabhu","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0470","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mehy.2017.10.016","article-title":"Artesunate-quercetin\/luteolin dual drug nanofacilitated synergistic treatment for malaria: a plausible approach to overcome artemisinin combination therapy resistance","volume":"109","author":"Puttappa","year":"2017","journal-title":"Med. Hypotheses"},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2019.04.020_bib0475","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijpharm.2017.04.042","article-title":"Recent advances in use of silver nanoparticles as antimalarial agents","volume":"526","author":"Rai","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0480","first-page":"123","article-title":"Development and characterization of artemether loaded solid lipid nanoparticles","volume":"47","author":"Raina","year":"2013","journal-title":"Ind. J. Pharm. Educ. Res."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0485","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1128\/AAC.01796-15","article-title":"Stearylamine liposomal delivery of monensin in combination with free artemisinin eliminates blood stages of Plasmodium falciparum in culture and P. berghei infection in murine malaria","volume":"60","author":"Rajendran","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.actatropica.2019.04.020_bib0490","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/10837450.2017.1372781","article-title":"Preparation and in vivo evaluation of anti-plasmodial properties of artemisinin-loaded PCL\u2013PEG\u2013PCL nanoparticles","volume":"23","author":"Ramazani","year":"2018","journal-title":"Pharm. Dev. Tech."},{"issue":"4-5","key":"10.1016\/j.actatropica.2019.04.020_bib0495","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.addr.2009.11.024","article-title":"Nanotechnology applied to the treatment of malaria","volume":"62","author":"Santos-Magalhaes","year":"2010","journal-title":"Adv. Drug. Del. Rev."},{"issue":"41","key":"10.1016\/j.actatropica.2019.04.020_bib0500","doi-asserted-by":"crossref","first-page":"5448","DOI":"10.1016\/j.vaccine.2017.02.040","article-title":"Development of a self-assembling protein nanoparticle vaccine targeting plasmodium falciparum circumsporozoite protein delivered in three army liposome formulation adjuvants","volume":"35","author":"Seth","year":"2017","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2019.04.020_bib0505","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijpharm.2007.06.035","article-title":"Formulation, antimalarial activity and biodistribution of oral lipid nanoemulsion of primaquine","volume":"347","author":"Singh","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.actatropica.2019.04.020_bib0510","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ijpharm.2011.01.050","article-title":"Evaluation of the physical properties and stability of two lipid drug delivery systems containing mefloquine","volume":"409","author":"Slabbert","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0515","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.exppara.2006.09.016","article-title":"In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models","volume":"115","author":"Snyder","year":"2007","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.actatropica.2019.04.020_bib0520","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/jac\/dkn330","article-title":"Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs","volume":"62","author":"Sousa","year":"2008","journal-title":"J. Antimicrob. Chemother."},{"issue":"8","key":"10.1016\/j.actatropica.2019.04.020_bib0525","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1017\/S0031182017002207","article-title":"Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice","volume":"145","author":"Souza","year":"2018","journal-title":"Parasitology"},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0530","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0378-5173(00)00338-0","article-title":"Formulation and characterisation of primaquine loaded liposomes prepared by a pH gradient using experimental design","volume":"198","author":"Stensrud","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.actatropica.2019.04.020_bib0535","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S1473-3099(17)30139-1","article-title":"DSM265 for Plasmodium falciparum Chemotherprophylaxis: a randomised, double blinded, phase 1 trial with controlled human malaria infection","volume":"17","author":"Sulyok","year":"2017","journal-title":"Lancet Inf. Dis."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0540","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1166\/jbn.2012.1366","article-title":"Preparation and characterization of monensin loaded PLGA nanoparticles: in vitro anti-malarial activity against Plasmodium falciparum","volume":"8","author":"Surolia","year":"2012","journal-title":"J. Biomed. Nanotech."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0545","first-page":"414","article-title":"Combating malaria with nanotechnology-based targeted and combinatorial drug delivery strategies","volume":"6","author":"Thakkar","year":"2016","journal-title":"Drug. Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.actatropica.2019.04.020_bib0550","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jconrel.2009.08.004","article-title":"Development and characterization of novel carrier gel core liposomes based transmission blocking malaria vaccine","volume":"140","author":"Tiwari","year":"2009","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.actatropica.2019.04.020_bib0555","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.actatropica.2013.07.011","article-title":"A novel chitosan based antimalarial drug delivery against Plasmodium berghei infection","volume":"128","author":"Tripathy","year":"2013","journal-title":"Acta Trop."},{"issue":"1","key":"10.1016\/j.actatropica.2019.04.020_bib0560","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1186\/1556-276X-6-620","article-title":"Study of the efficacy of antimalarial drugs delivered inside targeted immunoliposomal nanovectors","volume":"6","author":"Urban","year":"2011","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0565","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1038\/ncomms6521","article-title":"Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparum","volume":"5","author":"Vaidya","year":"2014","journal-title":"Nat. Commu."},{"issue":"6","key":"10.1016\/j.actatropica.2019.04.020_bib0570","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1086\/655831","article-title":"Arterolane, a new synthetic trioxolane for treatment of uncomplicated Plasmodium falciparum malaria: a phase II, multicenter, randomized, dose-finding clinical trial","volume":"51","author":"Valecha","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejps.2018.03.014","article-title":"Co-nanoencapsulation of antimalarial drugs increases their in vitro efficacy against Plasmodium falciparum and decreases their toxicity to Caenorhabditis elegans","volume":"118","author":"Velasques","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.actatropica.2019.04.020_bib0580","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkl563","article-title":"Antimalarial efficacy and drug interactions of the novel semi-synthetic endoperoxide artemisone in vitro and in vivo","volume":"59","author":"Vivas","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2019.04.020_bib0585","first-page":"78","article-title":"pH sensitive liposomes enhances immunogenicity of 19 kDa carboxyl-terminal fragment of Plasmodium falciparum","volume":"1","author":"Vyas","year":"2008","journal-title":"Int. J. Pharm. Sci. Nanotechnol."},{"issue":"7214","key":"10.1016\/j.actatropica.2019.04.020_bib0590","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nature07361","article-title":"Malaria research in the post-genomic era","volume":"455","author":"Winzeler","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.actatropica.2019.04.020_bib0595","series-title":"World Malaria Report","author":"World Health Organization","year":"2018"},{"issue":"5","key":"10.1016\/j.actatropica.2019.04.020_bib0600","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s13346-018-0537-1","article-title":"Optimization and evaluation of lipid emulsions for intravenous co-delivery of artemether and lumefantrine in severe malaria treatment","volume":"8","author":"Yang","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"issue":"9","key":"10.1016\/j.actatropica.2019.04.020_bib0605","first-page":"670","article-title":"Dihydroartemisinin loaded nanostructured lipid carriers (DHA-NLC): evaluation of pharmacokinetics and tissue distribution after intravenous administration to rats","volume":"65","author":"Zhang","year":"2010","journal-title":"Die Pharmazie Int. J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.actatropica.2019.04.020_bib0610","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.7150\/thno.22904","article-title":"Placenta-specific drug delivery by trophoblast-targeted nanoparticles in mice","volume":"8","author":"Zhang","year":"2018","journal-title":"Theranostics"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X1930350X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X1930350X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:15:26Z","timestamp":1757549726000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X1930350X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":122,"alternative-id":["S0001706X1930350X"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.04.020","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nano-facilitated drug delivery strategies in the treatment of plasmodium infection","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2019.04.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}